STOCK TITAN

ASTRONICS CORP (ATROB) SEC Filings

ATROB OTC Link

Welcome to our dedicated page for ASTRONICS SEC filings (Ticker: ATROB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ASTRONICS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ASTRONICS's regulatory disclosures and financial reporting.

Rhea-AI Summary

ASTRONICS CORP (ATRO) director Robert S. Keane reported an internal share reclassification on August 25, 2026. Boston & Saranac LLC, an entity indirectly associated with him, converted 76,000 Class B shares into 76,000 shares of $.01 par value common stock, all held indirectly. Keane also reports direct holdings of 13,934 common shares and 2,786 Class B shares, plus an additional indirect Class B position held in a trust where he is one of multiple beneficiaries with a proportionate interest below 25%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Astronics Corp (ATRO) reported that Executive VP & President–Aerospace Mark Peabody made a bona fide gift of 150 shares of $.01 par value common stock on 2026-08-18, leaving him with 62,232.73 common shares held directly. He also directly holds 232,610 Class B shares and multiple stock options on both common and Class B stock at exercise prices between $8.12 and $29.68 per share. In addition, he holds several performance-based restricted stock unit awards, including 15,900, 15,150 and 7,675 common-stock RSUs (and corresponding Class B RSUs) that may vest between 50% and 150% of target based on Astronics’ average annual adjusted EBITDA over three-year periods ending in 2026, 2027 and 2028.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

ASTRONICS CORP (ATRO) director Jeffry D. Frisby reported a bona fide gift of 2,000 shares of $.01 par value common stock on 2026-08-17, leaving him with 45,056 common shares held directly. He also holds 9,411 shares of $.01 par value Class B stock directly as of the same date.

In addition, Frisby continues to hold several option awards directly, including options over 4,000 common shares at $23.75 and 4,000 common shares at $28.37, plus options over 1,520 Class B shares at each of those exercise prices, with expirations in 2027 and 2028.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research report passive ownership in Astronics Corporation common stock. As of 06/30/2026, they collectively report beneficial ownership of 1,436,706 shares, representing 4.5% of the outstanding common stock.

The group reports sole voting power over 1,209,469 shares and sole dispositive power over 1,436,706 shares, with no shared voting or dispositive power. The filing is submitted jointly, with American Century Investment Management, Inc. acting as investment adviser and a wholly owned subsidiary of American Century Companies, Inc., which is controlled by the Stowers Institute for Medical Research.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Astronics Corporation reported substantially stronger results for the quarter and six months ended July 4, 2026. Six‑month sales rose to $490.6 million from $410.6 million, with net income up to $60.6 million from $10.8 million as gross margin improved to 33.0% from 27.7%. Diluted EPS increased to $1.31 from $0.25. Aerospace drove growth, with six‑month sales of $451.1 million and operating margin of 18.5%, helped by strong commercial transport and general aviation demand, improved efficiencies, lower litigation costs, absence of prior‑year restructuring charges, and a $2.0 million tariff refund. Test Systems returned to profitability, generating $39.5 million of sales and a modest operating profit versus a prior‑year loss.

Backlog reached $780.6 million, supported by a book‑to‑bill ratio above 1, and operating cash flow improved to $40.7 million. The company ended the quarter with $9.0 million in cash and $310.3 million of long‑term debt, including $258.0 million of convertible notes, and remained in compliance with all covenants while continuing to carry litigation reserves related to patent disputes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Capital International Investors filed as a significant shareholder of Astronics Corp. (common stock). The firm is deemed the beneficial owner of 264,925 shares, representing 5.8% of Astronics’ common stock, based on 4,572,336 shares believed to be outstanding. Capital International Investors reports sole voting power and sole dispositive power over all 264,925 shares, with no shared voting or dispositive authority. The filing notes that these shares are held on behalf of clients of various Capital Group investment management entities, including SMALLCAP World Fund, Inc., which may have the right to receive dividends or proceeds from the sale of the securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Astronics Corporation reported a very strong second quarter of 2026, with sales up 27.0% to $260.0 million and record operating income of $40.5 million, a 15.6% margin. Net income jumped to $35.1 million or $0.75 per diluted share, compared with $1.3 million or $0.03 a year earlier. Adjusted EBITDA reached $51.5 million, a margin of 19.8%.

The Aerospace segment drove results with record sales of $237.3 million, up 22.6%, and a 20.3% operating margin; General Aviation and Seat Motion posted especially strong growth. Test Systems sales more than doubled to $22.7 million, returning to a modest operating profit despite mix and under-absorption headwinds and some revenue recognized at no margin.

Bookings were a quarterly record at $306.2 million, producing a 1.18 book-to-bill and lifting total backlog to a record $780.6 million, with Aerospace backlog at $657.2 million. Year-to-date cash from operations was $40.7 million, long-term debt declined to $310.3 million, and available liquidity was $253.2 million. Management raised its 2026 revenue outlook to $1.02 billion–$1.04 billion and targets another quarterly sales record in the third quarter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

State Street Corporation and its affiliate SSGA Funds Management, Inc. report beneficial ownership of Astronics Corp common stock. They collectively beneficially own 14,821 shares, representing 0.1% of the outstanding common stock class, which is below the 5% large‑holder threshold.

The reporting persons have no sole voting or dispositive power over Astronics shares. They report shared voting power over 10,870 shares and shared dispositive power over 14,821 shares. The ownership is held through various State Street investment and advisory subsidiaries, including SSGA Funds Management, Inc., State Street Bank and Trust Company, and several State Street Global Advisors entities. The ownership is characterized as 5 percent or less of the class, with no other person identified as having more than 5 percent-related rights to dividends or sale proceeds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

BlackRock, Inc. filed an amended Schedule 13G reporting its beneficial ownership in Astronics Corp Class B Stock. As of July 31, 2026, BlackRock reported beneficial ownership of 82,314 Class B shares, representing 0.8% of the class. BlackRock reported 82,205 shares with sole voting power and 82,314 shares with sole dispositive power, with no shared voting or dispositive power. The filing notes that various persons have rights to dividends or sale proceeds related to these securities, but no single person has an interest exceeding five percent of Astronics’ total outstanding common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Dimensional Fund Advisors LP reported beneficial ownership of 345,139 shares of Astronics Corp common stock, representing 7.5% of the class, in a report dated 06/30/2026. Dimensional has sole voting power over 336,366 shares and sole dispositive power over 345,139 shares, with no shared voting or dispositive power.

The shares are held by investment funds and accounts advised or sub-advised by Dimensional. Dimensional may be deemed a beneficial owner for Section 13(d) purposes but disclaims beneficial ownership, noting that each underlying fund’s interest is below 5% of the class and that the funds retain rights to dividends and sale proceeds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership

FAQ

How many ASTRONICS (ATROB) SEC filings are available on StockTitan?

StockTitan tracks 57 SEC filings for ASTRONICS (ATROB), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for ASTRONICS (ATROB)?

The most recent SEC filing for ASTRONICS (ATROB) was filed on August 26, 2026.